Free Trial

Aldeyra Therapeutics (ALDX) SEC Filings & 10K Form

Aldeyra Therapeutics logo
$6.67 +0.41 (+6.55%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$6.61 -0.06 (-0.88%)
As of 03/28/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Aldeyra Therapeutics SEC Filings

DateFilerForm TypeView
03/28/2025
4:19 PM
Aldeyra Therapeutics (Filer)
Form 10-K/A
03/06/2025
3:13 PM
Aldeyra Therapeutics (Issuer)
Machatha Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
4:03 PM
Aldeyra Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2025
3:36 PM
Aldeyra Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/18/2024
6:01 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:50 PM
Aldeyra Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
10/21/2024
7:22 PM
Aldeyra Therapeutics (Issuer)
Miller-Rich Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:01 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
3:15 PM
Aldeyra Therapeutics (Issuer)
Alfieri Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2024
8:02 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
3:24 PM
Aldeyra Therapeutics (Issuer)
Greenberg Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:24 PM
Aldeyra Therapeutics (Issuer)
Machatha Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
5:07 PM
Aldeyra Therapeutics (Subject)
Greenberg Bruce (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
4:45 PM
Aldeyra Therapeutics (Subject)
Machatha Stephen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2024
6:06 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
6:01 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
6:01 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
6:01 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
11:15 PM
Aldeyra Therapeutics (Filer)
Form EFFECT
04/22/2024
3:11 PM
Aldeyra Therapeutics (Filer)
Form DEF 14A
04/22/2024
3:13 PM
Aldeyra Therapeutics (Filer)
Form DEFA14A
04/22/2024
3:18 PM
Aldeyra Therapeutics (Filer)
Form ARS
04/08/2024
4:32 PM
Aldeyra Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
4:22 PM
Aldeyra Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:ALDX) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners